Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal in neurotic excoriation
NCT00269594Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lamotrigine in Excoriation disorder (SPD), sponsored by University of Minnesota. Primary endpoint: Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation. Started Jan 2006; status: completed.
02
Drugs
lamotrigine
03
Conditions
Excoriation disorder (SPD)
Beyond the preview
Go deeper on NCT00269594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269594.